核RNAをターゲットにすることで,ミオトニック縮のインビボ矯正を行う
Thurman M Wheeler1, Andrew J Leger, Sanjay K Pandey
1Department of Neurology, University of Rochester, 601 Elmwood Avenue, Rochester, New York 14642, USA.
Nature
|August 4, 2012
まとめ
アンチセンセオリゴヌクレオチド (ASO) は,ミオトニクジストロフィー1型 (DM1) の有毒RNAを効果的に標的にします. マウスの全身的なASO治療は,疾患マーカーを急速に減らし,持続的な効果を示し,新しい治療戦略を提供しました.
科学分野:
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
- RNAセラピュティックス
背景:
- ミオトニックジストロフィー1型 (DM1) は,拡張CUG繰り返しの有毒RNAによって引き起こされる遺伝性疾患です.
- DM1の核を保持した変異性RNAは,機能の獲得効果を引き起こし,治療のターゲットにしています.
- 反感覚オリゴヌクレオチド (ASO) の全身的投与は,十分な組織吸収によって制限されています.
研究 の 目的:
- DM1.における遺伝子ノックダウンに対する全身的なASO投与の有効性を調査する.
- 核が保持したトランスクリプトが反感覚静音化に敏感であるかどうかを判断する.
- 核保持トランスクリプトの調節のための一般的な戦略としてASOを探求する.
主な方法:
- DM1.1のトランスジェニックマウスモデルを使用した.
- システム的に投与されたアンチセンスオリゴヌクレオチド (ASO)
- 骨格筋における拡張CUG (CUG(exp)) RNAとMalat1長い非コーディングRNA (lncRNA) のノックダウンを評価した.
- 病気の生理学的,ヒト病学的,および転写学的特徴を評価した.
主要な成果:
- システミックなASOは,DM1マウスの骨格筋のCUG (Exp) RNAを急速に減少させた.
- ASO治療は,疾患の特徴を修正し,効果は最大1年間持続しました.
- また,筋肉におけるMalat1 lncRNAの有効なノックダウンも達成されました.
- 核で保存されたトランスクリプトは,反意味サイレンシングに対する異常な敏感性を示した.
結論:
- システミックなASOは,DM1を含む核に残された有毒RNAをターゲットにするための実行可能な戦略です.
- このアプローチは,RNAの機能獲得疾患の持続的な治療効果を提供します.
- この発見は,拡張リピートおよび長時間核在留のlncRNAを調節するための一般化可能な方法を提供します.
関連する概念動画
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Mitochondrial Protein Sorting
Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death. Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...


